Calcium handling:a strategy to fight neurodegeneration in Alzheimer's disease

被引：0
|
作者：
Livia La Barbera [1 ,2 ]
Elena Spoleti [1 ]
Marcello D'Amelio [2 ,3 ]
机构：
[1] Department of Sciences and Technologies for Humans and Environment,Università Campus Bio-Medico di Roma
[2] Department of Experimental Neurosciences,IRCCS Santa Lucia Foundation  3. Department of Medicine and Surgery,Università Campus Bio-Medico di Roma
来源：
Neural Regeneration Research | 2023年 / 12期
关键词：
D O I：
暂无
中图分类号：
R749.16 [];
学科分类号：
100203 ;
摘要：
In the last few years,preclinical and clinical studies identified the ventral tegmental area(VTA) as one of the first brain regions to be affected in the prodromal phase of Alzheimer’s disease(AD).The VTA is a deep midbrain nucleus rich in dopaminergic neurons that innervates and releases dopamine(DA) in several cortical and subcortical brain regions.DA plays a crucial role in the modulation of both cognitive and noncognitive functions and failure of its release underlies both cognitive and neuropsychiatric symptoms in patients with AD.
引用
收藏
页码：2685 / 2686
页数：2
相关论文
共 50 条
  • [31] Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
    Xie, Anmu
    Gao, Jing
    Xu, Lin
    Meng, Dongmei
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [32] Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease
    Eleuteri, Simona
    Di Giovanni, Saviana
    Rockenstein, Edward
    Mante, Mike
    Adame, Antony
    Trejo, Margarita
    Wrasidlo, Wolf
    Wu, Fang
    Fraering, Patrick C.
    Masliah, Eliezer
    Lashuel, Hilal A.
    NEUROBIOLOGY OF DISEASE, 2015, 74 : 144 - 157
  • [33] Cerebrovascular disease, amyloid, and neurodegeneration in Alzheimer's disease progression
    Lao, Patrick
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [34] Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine
    Anekonda, Thimmappa S.
    Quinn, Joseph F.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (12): : 1584 - 1590
  • [35] APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease
    Parhizkar, Samira
    Holtzman, David M.
    SEMINARS IN IMMUNOLOGY, 2022, 59
  • [36] The Effects of Soluble Aβ Oligomers on Neurodegeneration in Alzheimer's Disease
    Brouillette, Jonathan
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (15) : 2506 - 2519
  • [37] Neurodegeneration and Alzheimer's disease: the lesson from tauopathies
    Sorrentino, G.
    Bonavita, V.
    NEUROLOGICAL SCIENCES, 2007, 28 (02) : 63 - 71
  • [38] Drawing on the brain’s resilience to fight Alzheimer’s disease
    Gravitz L.
    Nature, 2018, 559 (7715) : S8 - S9
  • [39] Neurodegeneration - from multiple sclerosis to Alzheimer's disease
    Meyerhof, Wolfgang
    Richter, Dietmar
    FEBS JOURNAL, 2013, 280 (18) : 4337 - 4337
  • [40] Problems of cell death in neurodegeneration and Alzheimer's Disease
    Jellinger, Kurt A.
    Stadelmann, Christine
    JOURNAL OF ALZHEIMERS DISEASE, 2001, 3 (01) : 31 - 40
12345